Literature DB >> 29395804

Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics.

Miloš Erak1, Kathrin Bellmann-Sickert1, Sylvia Els-Heindl1, Annette G Beck-Sickinger2.   

Abstract

The development of solid phase peptide synthesis has released tremendous opportunities for using synthetic peptides in medicinal applications. In the last decades, peptide therapeutics became an emerging market in pharmaceutical industry. The need for synthetic strategies in order to improve peptidic properties, such as longer half-life, higher bioavailability, increased potency and efficiency is accordingly rising. In this mini-review, we present a toolbox of modifications in peptide chemistry for overcoming the main drawbacks during the transition from natural peptides to peptide therapeutics. Modifications at the level of the peptide backbone, amino acid side chains and higher orders of structures are described. Furthermore, we are discussing the future of peptide therapeutics development and their impact on the pharmaceutical market.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lipidation; PEGylation; Peptide modifications; Peptide synthesis; Peptide therapeutics

Mesh:

Substances:

Year:  2018        PMID: 29395804     DOI: 10.1016/j.bmc.2018.01.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  45 in total

Review 1.  General lack of structural characterization of chemically synthesized long peptides.

Authors:  Jean A Boutin; André L Tartar; Alain van Dorsselaer; Hubert Vaudry
Journal:  Protein Sci       Date:  2019-03-25       Impact factor: 6.725

Review 2.  Trends in peptide drug discovery.

Authors:  Markus Muttenthaler; Glenn F King; David J Adams; Paul F Alewood
Journal:  Nat Rev Drug Discov       Date:  2021-02-03       Impact factor: 84.694

3.  The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules.

Authors:  Wenzhan Yang; Prajakta Gadgil; Venkata R Krishnamurthy; Margaret Landis; Pankajini Mallick; Dipal Patel; Phenil J Patel; Darren L Reid; Manuel Sanchez-Felix
Journal:  AAPS J       Date:  2020-01-03       Impact factor: 4.009

4.  Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity.

Authors:  Abigail N Smith; Daniel J Blackwell; Bjorn C Knollmann; Jeffrey N Johnston
Journal:  ACS Med Chem Lett       Date:  2021-11-23       Impact factor: 4.345

5.  Homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide improved HER2-overexpressed tumor targeting and imaging.

Authors:  Fatemeh Ebrahimi; Zohreh Noaparast; Seyed Mohammad Abedi; Seyed Jalal Hosseinimehr
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

6.  Toward Rapid Aspartic Acid Isomer Localization in Therapeutic Peptides Using Cyclic Ion Mobility Mass Spectrometry.

Authors:  Katherine Gibson; Dale A Cooper-Shepherd; Edward Pallister; Sophie E Inman; Sophie E Jackson; Viv Lindo
Journal:  J Am Soc Mass Spectrom       Date:  2022-05-24       Impact factor: 3.262

Review 7.  Battle of GLP-1 delivery technologies.

Authors:  Minzhi Yu; Mason M Benjamin; Santhanakrishnan Srinivasan; Emily E Morin; Ekaterina I Shishatskaya; Steven P Schwendeman; Anna Schwendeman
Journal:  Adv Drug Deliv Rev       Date:  2018-07-21       Impact factor: 15.470

8.  Preparation and Characterization of Quantum Dot-Peptide Conjugates Based on Polyhistidine Tags.

Authors:  Katherine D Krause; Hsin-Yun Tsai; Kelly Rees; Hyungki Kim; W Russ Algar
Journal:  Methods Mol Biol       Date:  2021

9.  Genome-Mining-Based Discovery of the Cyclic Peptide Tolypamide and TolF, a Ser/Thr Forward O-Prenyltransferase.

Authors:  Mugilarasi Purushothaman; Snigdha Sarkar; Maho Morita; Muriel Gugger; Eric W Schmidt; Brandon I Morinaka
Journal:  Angew Chem Int Ed Engl       Date:  2021-03-05       Impact factor: 15.336

Review 10.  Biologics and their delivery systems: Trends in myocardial infarction.

Authors:  Matthew A Borrelli; Heth R Turnquist; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-03-26       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.